Introduction: Triple-negative breast cancer (TNBC) accounts for approximately 15% of breast cancers. BRCA1 mutations occur in up to 20% of TNBC cases; simultaneous pathogenic variants in BRCA1 and PALB2 in a single patient are exceedingly rare, with poorly characterized combined clinical implications.
Case report: A 5...
Samuel Castro Campos, Sabas Carlos Vieira· Mastology· 0 citations
Introduction: Bilateral breast cancer (BBC) represents 2%–12% of breast cancer cases, and can be synchronous or metachronous, accounting for approximately 2.9–3.9% and 4.1–4.6% of all new cases, respectively. Factors associated with a worse prognosis include mutations in the BRCA1 and BRCA2 genes, biomarker expression,...
Sabas Carlos Vieira, Isabela Cristina Carvalho Bandeira Coelho, W. M. N. Eulálio· Mastology· 0 citations
Introduction: Breast cancer is the most frequently diagnosed malignancy in women worldwide, and improved survival has led to an increasing incidence of multiple primary tumors. The association between breast cancer and gynecological neoplasms, including cervical cancer, remains clinically relevant and may reflect both...
Guilherme Coelho Carvalho, Sabas Carlos Vieira· Mastology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.